Atrial fibrillation differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Line 249: Line 249:
* Stroke
* Stroke
|-
|-
|'''Ventricular Tacycardia'''
|'''Ventricular Tacycardia'''<ref name="pmid19252119">{{cite journal |vauthors=Koplan BA, Stevenson WG |title=Ventricular tachycardia and sudden cardiac death |journal=Mayo Clin. Proc. |volume=84 |issue=3 |pages=289–97 |date=March 2009 |pmid=19252119 |pmc=2664600 |doi=10.1016/S0025-6196(11)61149-X |url=}}</ref>
|
|
* Regular
* Regular
Line 271: Line 271:
* Arrhythmogenic right ventricular dysplasia
* Arrhythmogenic right ventricular dysplasia
* Myocardial infarction
* Myocardial infarction
*Torsades de pointes is a form of polymorphic VT that is often associated with a prolonged QT interval.
|}
|}



Revision as of 05:22, 16 December 2019



Resident
Survival
Guide


Sinus rhythm
Atrial fibrillation

Atrial Fibrillation Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Atrial Fibrillation from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Special Groups

Postoperative AF
Acute Myocardial Infarction
Wolff-Parkinson-White Preexcitation Syndrome
Hypertrophic Cardiomyopathy
Hyperthyroidism
Pulmonary Diseases
Pregnancy
ACS and/or PCI or valve intervention
Heart failure

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

EKG Examples
A-Fib with LBBB

Chest X Ray

Echocardiography

Holter Monitoring and Exercise Stress Testing

Cardiac MRI

Treatment

Rate and Rhythm Control

Cardioversion

Overview
Electrical Cardioversion
Pharmacological Cardioversion

Anticoagulation

Overview
Warfarin
Converting from or to Warfarin
Converting from or to Parenteral Anticoagulants
Dabigatran

Maintenance of Sinus Rhythm

Surgery

Catheter Ablation
AV Nodal Ablation
Surgical Ablation
Cardiac Surgery

Specific Patient Groups

Primary Prevention

Secondary Prevention

Supportive Trial Data

Cost-Effectiveness of Therapy

Case Studies

Case #1

Atrial fibrillation differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Atrial fibrillation differential diagnosis

CDC on Atrial fibrillation differential diagnosis

Atrial fibrillation differential diagnosis in the news

Blogs on Atrial fibrillation differential diagnosis

Directions to Hospitals Treating Atrial fibrillation differential diagnosis

Risk calculators and risk factors for Atrial fibrillation differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Atrial fibrillation must be distinguished from other common atrial arrhythmias, which include atrial flutter, atrial tachycardia, paroxysmal supraventricular tachycardia, Wolff-Parkinson-White syndrome, and atrioventricular nodal reentry tachycardia.

Differentiating Atrial Fibrillation from other Diseases

Atrial fibrillation has to be differnetiated from other diseases like:

The differentiating features are largely based on both EKG findings and cardiovascular examination.


Arrhythmia Rhythm Rate P wave PR Interval QRS Complex Response to Maneuvers Epidemiology Co-existing Conditions
Atrial Fibrillation (AFib)[1][2]
  • Irregularly irregular
  • On a 10-second 12-lead EKG strip, multiply number of QRS complexes by 6
  • Absent, fibrillatory waves
  • Absent
  • Less than 0.12 seconds, consistent, and normal in morphology in the absence of aberrant conduction
  • Does not break with adenosine or vagal maneuvers
  • 2.7–6.1 million people in the United States have AFib
  • 2% of people younger than age 65 have AFib, while about 9% of people aged 65 years or older have AFib
  • Elderly
  • Following bypass surgery
  • Mitral valve disease
  • Hyperthyroidism
  • Diabetes
  • Heart failure
  • Ischemic heart disease
  • Chronic kidney disease
  • Heavy alcohol use
  • Left chamber enlargement
Atrial Flutter[3]
  • Regular or Irregular
  • 75 (4:1 block), 100 (3:1 block) and 150 (2:1 block) beats per minute (bpm), but 150 is more common
  • Sawtooth pattern of P waves at 250 to 350 bpm
  • Biphasic deflection in V1
  • Varies depending upon the magnitude of the block, but is short
  • Less than 0.12 seconds, consistent, and normal in morphology
  • Conduction may vary in response to drugs and maneuvers dropping the rate from 150 to 100 or to 75 bpm
  • Incidence: 88 per 100,000 individuals
  • Elderly
  • Alcohol
Atrioventricular nodal reentry tachycardia (AVNRT)[4][5][6][7]
  • Regular
  • 140-280 bpm
  • Slow-Fast AVNRT:
    • Pseudo-S wave in Leads II, III, and AVF
    • Pseudo-R' in lead V1.
  • Fast-Slow AVNRT
    • P waves between the QRS and T waves (QRS-P-T complexes)
  • Slow-Slow AVNRT
    • Late P waves after a QRS
    • Often appears as atrial tachycardia.
  • Inverted, superimposed on or buried within the QRS complex (pseudo R prime in V1/pseudo S wave in inferior leads)
  • Absent (P wave can appear after the QRS complex and before the T wave, and in atypical AVNRT, the P wave can appear just before the QRS complex)
  • Less than 0.12 seconds, consistent, and normal in morphology in the absence of aberrant conduction
  • QRS alternans may be present
  • May break with adenosine or vagal maneuvers
  • 60%-70% of all SVTs
  • Structural heart disease
  • Atrial tachyarrhythmias
Multifocal Atrial Tachycardia[8][9]
  • Irregular
  • Atrial rate is > 100 beats per minute
  • Varying morphology from at least three different foci
  • Absence of one dominant atrial pacemaker, can be mistaken for atrial fibrillation if the P waves are of low amplitude
  • Variable PR intervals, RR intervals, and PP intervals
  • Less than 0.12 seconds, consistent, and normal in morphology
  • Does not terminate with adenosine or vagal maneuvers
  • 0.05% to 0.32% of electrocardiograms in general hospital admissions
  • Elderly
  • COPD
Paroxysmal Supraventricular Tachycardia
  • Regular
  • 150 and 240 bpm
  • Absent
  • Hidden in QRS
  • Absent
  • Narrow complexes (< 0.12 s)
  • Breaks with vagal maneuvers, adenosine, diving reflex, oculocardiac reflex
  • Prevalence: 0.023 per 100,000
  • Alcohol
  • Caffeine
  • Nicotine
  • Psychological stress
  • Wolff-Parkinson-White syndrome
Premature Atrial Contractrions (PAC)[10][11]
  • Regular except when disturbed by premature beat(s)
  • 80-120 bpm
  • Upright
  • > 0.12 second
  • May be shorter than that in normal sinus rhythm (NSR) if the origin of PAC is located closer to the AV node
  • Ashman’s Phenomenon:
    • PAC displaying a right bundle branch block pattern
  • Usually narrow (< 0.12 s)
  • Breaks with vagal maneuvers, adenosine, diving reflex, oculocardiac reflex
  • Infants
  • Cardiomyopathy
  • Myocarditis
  • Elderly
  • Coronary artery disease
  • Stroke
  • Increased atrial natruiretic peptide (ANP)
  • Hypercholesterolemia
Wolff-Parkinson-White Syndrome[12][13]
  • Regular
  • Atrial rate is nearly 300 bpm and ventricular rate is at 150 bpm
  • With orthodromic conduction due to a bypass tract, the P wave generally follows the QRS complex, whereas in AVNRT, the P wave is generally buried in the QRS complex.
  • Less than 0.12 seconds
  • A delta wave and evidence of ventricular pre-excitation if there is conduction to the ventricle via ante-grade conduction down an accessory pathway
  • A delta wave and pre-excitation may not be present because bypass tracts do not conduct ante-grade.
  • May break in response to procainamide, adenosine, vagal maneuvers
  • Worldwide prevalence of WPW syndrome is 100 - 300 per 100,000
  • Ebstein's anomaly
  • Mitral valve prolapse: This cardiac disorder, if present, is associated with left-sided accessory pathways.
  • Hypertrophic cardiomyopathy: This disorder is associated with familial/inherited form of WPW syndrome.
  • Hypokalemic periodic paralysis
  • Pompe disease
  • Tuberous sclerosis
Ventricular Fibrillation (VF)[14][15][16]
  • Irregular
  • 150 to 500 bpm
  • Absent
  • Absent
  • Absent (R on T phenomenon in the setting of ischemia)
  • Does not break in response to procainamide, adenosine, vagal maneuvers
  • 3-12% cases of acute myocardial infarction (AMI)
  • Out of 356,500 out of hospital cardiac arrests, 23% have VF as initial rhythm
  • Myocardial ischemia / infarction
  • Cardiomyopathy
  • Channelopathies e.g. Long QT (acquired / congenital)
  • Electrolyte abnormalities (hypokalemia/hyperkalemia, hypomagnesemia)
  • Aortic stenosis
  • Aortic dissection
  • Myocarditis
  • Cardiac tamponade
  • Blunt trauma (Commotio Cordis)
  • Sepsis
  • Hypothermia
  • Pneumothroax
  • Seizures
  • Stroke
Ventricular Tacycardia[17]
  • Regular
  • > 100 beats per minute
  • Wide complex, QRS duration > 120 milliseconds
  • Does not break in response to procainamide, adenosine, vagal maneuvers
  • 5-10% of patients presenting with AMI
  • Coronary artery disease
  • Aortic stenosis
  • Cardiomyopathy,
  • Electrolyte imbalances (e.g., hypokalemia, hypomagnesemia)
  • Inherited channelopathies (e.g., long-QT syndrome),
  • Catecholaminergic polymorphic ventricular tachycardia
  • Arrhythmogenic right ventricular dysplasia
  • Myocardial infarction
  • Torsades de pointes is a form of polymorphic VT that is often associated with a prolonged QT interval.

References

  1. Lankveld TA, Zeemering S, Crijns HJ, Schotten U (July 2014). "The ECG as a tool to determine atrial fibrillation complexity". Heart. 100 (14): 1077–84. doi:10.1136/heartjnl-2013-305149. PMID 24837984.
  2. Harris K, Edwards D, Mant J (2012). "How can we best detect atrial fibrillation?". J R Coll Physicians Edinb. 42 Suppl 18: 5–22. doi:10.4997/JRCPE.2012.S02. PMID 22518390.
  3. Cosío FG (June 2017). "Atrial Flutter, Typical and Atypical: A Review". Arrhythm Electrophysiol Rev. 6 (2): 55–62. doi:10.15420/aer.2017.5.2. PMC 5522718. PMID 28835836.
  4. Katritsis DG, Josephson ME (August 2016). "Classification, Electrophysiological Features and Therapy of Atrioventricular Nodal Reentrant Tachycardia". Arrhythm Electrophysiol Rev. 5 (2): 130–5. doi:10.15420/AER.2016.18.2. PMC 5013176. PMID 27617092.
  5. Letsas KP, Weber R, Siklody CH, Mihas CC, Stockinger J, Blum T, Kalusche D, Arentz T (April 2010). "Electrocardiographic differentiation of common type atrioventricular nodal reentrant tachycardia from atrioventricular reciprocating tachycardia via a concealed accessory pathway". Acta Cardiol. 65 (2): 171–6. doi:10.2143/AC.65.2.2047050. PMID 20458824.
  6. "Atrioventricular Nodal Reentry Tachycardia (AVNRT) - StatPearls - NCBI Bookshelf".
  7. Schernthaner C, Danmayr F, Strohmer B (2014). "Coexistence of atrioventricular nodal reentrant tachycardia with other forms of arrhythmias". Med Princ Pract. 23 (6): 543–50. doi:10.1159/000365418. PMC 5586929. PMID 25196716.
  8. Scher DL, Arsura EL (September 1989). "Multifocal atrial tachycardia: mechanisms, clinical correlates, and treatment". Am. Heart J. 118 (3): 574–80. doi:10.1016/0002-8703(89)90275-5. PMID 2570520.
  9. Goodacre S, Irons R (March 2002). "ABC of clinical electrocardiography: Atrial arrhythmias". BMJ. 324 (7337): 594–7. doi:10.1136/bmj.324.7337.594. PMC 1122515. PMID 11884328.
  10. Lin CY, Lin YJ, Chen YY, Chang SL, Lo LW, Chao TF, Chung FP, Hu YF, Chong E, Cheng HM, Tuan TC, Liao JN, Chiou CW, Huang JL, Chen SA (August 2015). "Prognostic Significance of Premature Atrial Complexes Burden in Prediction of Long-Term Outcome". J Am Heart Assoc. 4 (9): e002192. doi:10.1161/JAHA.115.002192. PMC 4599506. PMID 26316525.
  11. Strasburger JF, Cheulkar B, Wichman HJ (December 2007). "Perinatal arrhythmias: diagnosis and management". Clin Perinatol. 34 (4): 627–52, vii–viii. doi:10.1016/j.clp.2007.10.002. PMC 3310372. PMID 18063110.
  12. Rao AL, Salerno JC, Asif IM, Drezner JA (July 2014). "Evaluation and management of wolff-Parkinson-white in athletes". Sports Health. 6 (4): 326–32. doi:10.1177/1941738113509059. PMC 4065555. PMID 24982705.
  13. Rosner MH, Brady WJ, Kefer MP, Martin ML (November 1999). "Electrocardiography in the patient with the Wolff-Parkinson-White syndrome: diagnostic and initial therapeutic issues". Am J Emerg Med. 17 (7): 705–14. doi:10.1016/s0735-6757(99)90167-5. PMID 10597097.
  14. Glinge C, Sattler S, Jabbari R, Tfelt-Hansen J (September 2016). "Epidemiology and genetics of ventricular fibrillation during acute myocardial infarction". J Geriatr Cardiol. 13 (9): 789–797. doi:10.11909/j.issn.1671-5411.2016.09.006. PMC 5122505. PMID 27899944.
  15. Samie FH, Jalife J (May 2001). "Mechanisms underlying ventricular tachycardia and its transition to ventricular fibrillation in the structurally normal heart". Cardiovasc. Res. 50 (2): 242–50. doi:10.1016/s0008-6363(00)00289-3. PMID 11334828.
  16. Adabag AS, Luepker RV, Roger VL, Gersh BJ (April 2010). "Sudden cardiac death: epidemiology and risk factors". Nat Rev Cardiol. 7 (4): 216–25. doi:10.1038/nrcardio.2010.3. PMC 5014372. PMID 20142817.
  17. Koplan BA, Stevenson WG (March 2009). "Ventricular tachycardia and sudden cardiac death". Mayo Clin. Proc. 84 (3): 289–97. doi:10.1016/S0025-6196(11)61149-X. PMC 2664600. PMID 19252119.

CME Category::Cardiology